241 related articles for article (PubMed ID: 7967189)
1. [123I-MIBG myocardial scintigraphy in diabetic patients: association with autonomic neuropathy].
Nagamachi S; Hoshi H; Ohnishi T; Jinnouchi S; Futami S; Watanabe K; Nakatsuru K; Toshimori T; Matsukura S
Kaku Igaku; 1994 Sep; 31(9):1059-69. PubMed ID: 7967189
[TBL] [Abstract][Full Text] [Related]
2. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship to autonomic neuropathy.
Nagamachi S; Jinnouchi S; Nakahara H; Flores LG; Ohnishi T; Hoshi H; Futami S; Watanabe K; Nakatsuru K; Toshimori T; Matsukura S
Nucl Med Commun; 1996 Jul; 17(7):621-32. PubMed ID: 8843123
[TBL] [Abstract][Full Text] [Related]
3. 123I-MIBG myocardial scintigraphy in diabetic patients: relationship with 201Tl uptake and cardiac autonomic function.
Nagamachi S; Jinnouchi S; Kurose T; Ohnishi T; Flores LG; Nakahara H; Futami S; Tamura S; Matsukura S
Ann Nucl Med; 1998 Dec; 12(6):323-31. PubMed ID: 9972369
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
[TBL] [Abstract][Full Text] [Related]
5. Regional abnormality of iodine-123-MIBG in diabetic hearts.
Hattori N; Tamaki N; Hayashi T; Masuda I; Kudoh T; Tateno M; Tadamura E; Yonekura Y; Nakao K; Konishi J
J Nucl Med; 1996 Dec; 37(12):1985-90. PubMed ID: 8970519
[TBL] [Abstract][Full Text] [Related]
6. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability.
Murata K; Sumida Y; Murashima S; Matsumura K; Takeda H; Nakagawa T; Shima T
Diabet Med; 1996 Mar; 13(3):266-72. PubMed ID: 8689849
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of myocardial imaging by 123I-MIBG in assessment of diabetic neuropathy].
Katono E; Owada K; Takeda H; Techigawara M; Watanabe N; Maruyama Y
Kaku Igaku; 1993 Oct; 30(10):1235-9. PubMed ID: 8264114
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine.
Kim SJ; Lee JD; Ryu YH; Jeon P; Shim YW; Yoo HS; Park CY; Lim SG
Eur J Nucl Med; 1996 Apr; 23(4):401-6. PubMed ID: 8612660
[TBL] [Abstract][Full Text] [Related]
9. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus.
Mäntysaari M; Kuikka J; Mustonen J; Tahvanainen K; Vanninen E; Länsimies E; Uusitupa M
Clin Auton Res; 1996 Jun; 6(3):163-9. PubMed ID: 8832126
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction.
Miyanaga H; Yoneyama S; Kamitani T; Kawasaki S; Takahashi T; Kunishige H
Jpn Circ J; 1995 Sep; 59(9):599-607. PubMed ID: 7500543
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.
Schnell O; Kirsch CM; Stemplinger J; Haslbeck M; Standl E
Diabetologia; 1995 Nov; 38(11):1345-52. PubMed ID: 8582545
[TBL] [Abstract][Full Text] [Related]
12. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Langer A; Freeman MR; Josse RG; Armstrong PW
J Am Coll Cardiol; 1995 Mar; 25(3):610-8. PubMed ID: 7860904
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy.
Langen KJ; Ziegler D; Weise F; Piolot R; Boy C; Hübinger A; Gries FA; Müller-Gärtner HW
Clin Sci (Lond); 1997 Oct; 93(4):325-33. PubMed ID: 9404224
[TBL] [Abstract][Full Text] [Related]
14. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].
Narita M; Kurihara T; Murano K; Usami M; Honda M
Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231
[TBL] [Abstract][Full Text] [Related]
15. Abnormal myocardial uptake and clearance of 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction.
Miyanaga H; Yoneyama S; Kamitani T; Kawasaki S; Takahashi T; Kunishige H
J Nucl Cardiol; 1996; 3(6 Pt 1):508-15. PubMed ID: 8989675
[TBL] [Abstract][Full Text] [Related]
16. [123I-MIBG lung uptake in patients with diabetes mellitus].
Nagamachi S; Jinnouchi S; Flores LG; Ohnishi T; Futami S; Nakahara H; Tamura S; Watanabe K; Kurose T; Matsukura S
Kaku Igaku; 1997 Sep; 34(9):797-805. PubMed ID: 9394546
[TBL] [Abstract][Full Text] [Related]
17. [123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder].
Hakusui S; Yasuda T; Yanagi T; Takahashi A; Hasegawa Y; Inoue M
Rinsho Shinkeigaku; 1994 Apr; 34(4):402-4. PubMed ID: 8026141
[TBL] [Abstract][Full Text] [Related]
18. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects.
Morozumi T; Kusuoka H; Fukuchi K; Tani A; Uehara T; Matsuda S; Tsujimura E; Ito Y; Hori M; Kamada T; Nishimura T
J Nucl Med; 1997 Jan; 38(1):49-52. PubMed ID: 8998149
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM.
Turpeinen AK; Vanninen E; Kuikka JT; Uusitupa MI
Diabetes Care; 1996 Oct; 19(10):1083-90. PubMed ID: 8886553
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of 123I-metaiodobenzylguanidine myocardial scintigram in patients with valvular heart disease].
Terada K; Sugihara H; Shiga K; Ohtsuki K; Ito K; Taniguchi Y; Azuma A; Kohno Y; Miyao K; Nakagawa M
J Cardiol; 1995 May; 25(5):247-53. PubMed ID: 7776194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
